Marvell Agreed to Buy Lumentum in Stock, and the Offer Shrank by a Third

Marvell announced a merger agreement with optical connectivity maker Lumentum on Monday morning. According to the companies, the deal values Lumentum at an enterprise value of $115 billion, or about $1,132 per share.

The stocks greeted the deal with selling. By the close, Marvell was down 12.7% and Lumentum down 18.6%, and the offer's per-share value had shrunk to $771.

What the Deal Brings

Payment is entirely in stock. At closing, Marvell holders will own about 67% of the combined company and Lumentum holders about 33%. Matt Murphy stays on as chairman and CEO.

The rationale is the shift of data center connectivity from electrical signals to light. Marvell brings interconnect and custom chip design; Lumentum brings lasers, transceivers and indium phosphide manufacturing.

The companies expect more than $1 billion in annual cost savings and accretion to earnings per share in the first year. Murphy put it this way: "AI infrastructure is undergoing a fundamental architectural shift toward optical connectivity."

Why the Offer Changes Every Day

This is not a cash offer. What a Lumentum holder receives is not dollars but 4.5 shares of Marvell.

Marvell has lost 31.9% since October 28, and the offer shrank by the same proportion. Lumentum's 23.9% premium is gone; the stock now sits about 25% below its unaffected price.

An investor who wants the gap buys Lumentum and shorts 4.5 Marvell shares against it. That removes the bet on Marvell's direction and leaves only the bet on the deal closing. The structure can put selling pressure on the acquirer in stock deals; sources tied today's drop to dilution concerns.

The gap is wide because the wait is long. The agreement's first outside date is November 1, 2027; if approvals lag it can be extended three times, to August 1, 2028. Marvell owes $5.8 billion if it walks away and $3.2 billion if regulators block the deal.

The Drop Was Specific to the Deal

The fund tracking the Nasdaq 100 closed down 1.0%, with a sharp fall in oil setting the tone for the rest of the day. The losses in Marvell and Lumentum were more than ten times larger.

Rival optical maker Coherent, meanwhile, rose 3.8% in premarket trading. TheStreet attributed the gain to the deal news; Coherent now remains one of the large independent optical suppliers.

The chart covers the past month, including the days when talks leaked. Lumentum had already fallen 8.6% on October 30, before the deal was announced.

What the Seller's Timing Says

Citrini Research analyst Jukan, according to reports, read the sale as a sign that management does not trust the AI cycle. His post on X read: "They think the market will collapse in two to three years."

The weak point of that reading is the form of payment. Lumentum holders are not taking cash; they stay in the cycle by holding a third of the combined company.

Nor does the business show signs of weakening. Lumentum lifted fiscal first-quarter revenue 136.5% to $1.26 billion and guided the second quarter to $1.6 billion, against expectations of $1.48 billion.

What It Means for Investors

• The market is pricing a likely close but demands a 12.7% discount for it; if that gap narrows, approval risk is falling.
• Lumentum will now trade less like a standalone optical stock and more like 4.5 times Marvell; a Marvell decline hits both.
• Coherent will test with Wednesday's earnings how much takeover expectation is already in its price.
• The risk that breaks the thesis is approvals running past mid-2028; in that case Lumentum's remaining protection is the $3.2 billion fee.

For background, see What Long and Short Mean and Market Capitalization.

Deal terms come from Marvell's November 2 press release and Lumentum's 8-K filing with the SEC. Closing prices are based on StockTitan and 24/7 Wall St. closing data. Lumentum's quarterly results and its October 30 move come from The Motley Fool and Yahoo Finance reports. Jukan's remark is a secondhand report. The October 28 Marvell price was calculated by dividing the $1,132 offer by 4.5.